Pfizer and BioNTech Seek Full FDA Approval for Coronavirus Vaccine

Dr. Jonathan Javitt, CEO of NeuroRx and adjunct professor at Johns Hopkins School of Medicine, discusses the latest vaccine developments, from a new vaccine FDA request to the WHO's approval of a Chinese vaccine.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.